Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma

References

• Rizvi S, Gores GJ. Pathogenesis, diagnosis, and management of cholangiocarcinoma. Gastroenterology 2013; 145:1215-29; PMID:24140396; http://dx.doi.org/10.1053/j.gastro.2013.10.013
   PubMed Web of Science ®Google Scholar
• Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8:512-22; PMID:21808282; http://dx.doi.org/10.1038/nrgastro.2011.131
   PubMed Web of Science ®Google Scholar
• Ong CK, Subimerb C, Pairojkul C, Wongkham S, Cutcutache I, Yu W, McPherson JR, Allen GE, Ng CC, Wong BH, et al. Exome sequencing of liver fluke-associated cholangiocarcinoma. Nat Genet 2012; 44:690-3; PMID:22561520; http://dx.doi.org/10.1038/ng.2273
   PubMed Web of Science ®Google Scholar
• Chan-On W, Nairismagi ML, Ong CK, Lim WK, Dima S, Pairojkul C, Lim KH, McPherson JR, Cutcutache I, Heng HL, et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet 2013; 45:1474-8; PMID:24185513; http://dx.doi.org/10.1038/ng.2806
   PubMed Web of Science ®Google Scholar
• Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 2013; 45:1470-3; PMID:24185509; http://dx.doi.org/10.1038/ng.2813
   PubMed Web of Science ®Google Scholar
• Costello JF, Plass C. Methylation matters. J Med Genet 2001; 38:285-303; PMID:11333864; http://dx.doi.org/10.1136/jmg.38.5.285
   PubMed Web of Science ®Google Scholar
• Goeppert B, Konermann C, Schmidt CR, Bogatyrova O, Geiselhart L, Ernst C, Gu L, Becker N, Zucknick M, Mehrabi A, et al. Global alterations of DNA methylation in cholangiocarcinoma targets the Wnt signaling pathway. Hepatology 2014; 59:544-54; PMID:24002901; http://dx.doi.org/10.1002/hep.26721
   PubMed Web of Science ®Google Scholar
• Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Gitt A, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Res 2007; 67:1424-9; PMID:17308079; http://dx.doi.org/10.1158/0008-5472.CAN-06-4218
   PubMed Web of Science ®Google Scholar
• Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008; 105:13556-61; PMID:18768788; http://dx.doi.org/10.1073/pnas.0803055105
   PubMed Web of Science ®Google Scholar
• Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008; 68:4123-32; PMID:18519671; http://dx.doi.org/10.1158/0008-5472.CAN-08-0325
   PubMed Web of Science ®Google Scholar
• Baer C, Claus R, Frenzel LP, Zucknick M, Park YJ, Gu L, Weichenhan D, Fischer M, Pallasch CP, Herpel E, et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res 2012; 72:3775-85; PMID:22710432; http://dx.doi.org/10.1158/0008-5472.CAN-12-0803
   PubMed Web of Science ®Google Scholar
• Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D. Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinogenesis 2013; 52:297-303; PMID:22213236; http://dx.doi.org/10.1002/mc.21864
   PubMed Web of Science ®Google Scholar
• Xie B, Ding Q, Han H, Wu D. miRCancer: a microRNA-cancer association database constructed by text mining on literature. Bioinformatics 2013; 29:638-44; PMID:23325619; http://dx.doi.org/10.1093/bioinformatics/btt014
   PubMed Web of Science ®Google Scholar
• Peng F, Jiang J, Yu Y, Tian R, Guo X, Li X, Shen M, Xu M, Zhu F, Shi C, et al. Direct targeting of SUZ12/ROCK2 by miR-200b/c inhibits cholangiocarcinoma tumourigenesis and metastasis. Br J Cancer 2013; 109:3092-104; PMID:24169343; http://dx.doi.org/10.1038/bjc.2013.655
   PubMed Web of Science ®Google Scholar
• Vlachos IS, Kostoulas N, Vergoulis T, Georgakilas G, Reczko M, Maragkakis M, Paraskevopoulou MD, Prionidis K, Dalamagas T, Hatzigeorgiou AG. DIANA miRPath v.2.0: investigating the combinatorial effect of microRNAs in pathways. Nucleic Acids Res 2012; 40:W498-504; PMID:22649059; http://dx.doi.org/10.1093/nar/gks494
   PubMed Web of Science ®Google Scholar
• Jinawath N, Chamgramol Y, Furukawa Y, Obama K, Tsunoda T, Sripa B, Pairojkul C, Nakamura Y. Comparison of gene expression profiles between Opisthorchis viverrini and non-Opisthorchis viverrini associated human intrahepatic cholangiocarcinoma. Hepatology 2006; 44:1025-38; PMID:17006947; http://dx.doi.org/10.1002/hep.21330
   PubMed Web of Science ®Google Scholar
• Obama K, Ura K, Li M, Katagiri T, Tsunoda T, Nomura A, Satoh S, Nakamura Y, Furukawa Y. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology 2005; 41:1339-48; PMID:15880566; http://dx.doi.org/10.1002/hep.20718
   PubMed Web of Science ®Google Scholar
• Borad MJ, Champion MD, Egan JB, Liang WS, Fonseca R, Bryce AH, McCullough AE, Barrett MT, Hunt K, Patel MD, et al. Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma. PLoS Genet 2014; 10:e1004135; PMID:24550739; http://dx.doi.org/10.1371/journal.pgen.1004135
   PubMed Web of Science ®Google Scholar
• Haga H, Yan I, Takahashi K, Wood J, Patel T. Emerging insights into the role of microRNAs in the pathogenesis of cholangiocarcinoma. Gene Expression 2014; 16:93-9; PMID:24801170; http://dx.doi.org/10.3727/105221614X13919976902174
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang L, Zhang T, Hao M, Zhang X, Zhang J, Xie Q, Wang Y, Guo M, Zhuang H, et al. Methylation-mediated repression of microRNA 129-2 enhances oncogenic SOX4 expression in HCC. Liver Int: Official J Int Association For Study Liver 2013; 33:476-86; PMID:23402613; http://dx.doi.org/10.1111/liv.12097
   PubMed Web of Science ®Google Scholar
• Huang YW, Liu JC, Deatherage DE, Luo J, Mutch DG, Goodfellow PJ, Miller DS, Huang TH. Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 oncogene in endometrial cancer. Cancer Res 2009; 69:9038-46; PMID:19887623; http://dx.doi.org/10.1158/0008-5472.CAN-09-1499
   PubMed Web of Science ®Google Scholar
• Brest P, Lassalle S, Hofman V, Bordone O, Gavric Tanga V, Bonnetaud C, Moreilhon C, Rios G, Santini J, Barbry P, et al. MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells. Endocrine-Related Cancer 2011; 18:711-9; PMID:21946411; http://dx.doi.org/10.1530/ERC-10-0257
   PubMed Web of Science ®Google Scholar
• Kang M, Li Y, Liu W, Wang R, Tang A, Hao H, Liu Z, Ou H. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression. Internat J Mol Med 2013; 32:51-8; PMID:23677061; http://dx.doi.org/10.3892/ijmm.2013.1384
   PubMed Web of Science ®Google Scholar
• Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, Langer F, Kreipe H. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 2008; 214:17-24; PMID:17948228; http://dx.doi.org/10.1002/path.2251
   PubMed Web of Science ®Google Scholar
• Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, Chan WC, Ho MR, Lai CH, Kao HW, Fang WL, et al. Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics 2011; 6:1189-97; PMID:21931274; http://dx.doi.org/10.4161/epi.6.10.16535
   PubMed Web of Science ®Google Scholar
• Meng F, Wehbe-Janek H, Henson R, Smith H, Patel T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008; 27:378-86; PMID:17621267; http://dx.doi.org/10.1038/sj.onc.1210648
   PubMed Web of Science ®Google Scholar
• Kim TY, Vigil D, Der CJ, Juliano RL. Role of DLC-1, a tumor suppressor protein with RhoGAP activity, in regulation of the cytoskeleton and cell motility. Cancer Metastasis Rev 2009; 28:77-83; PMID:19221866; http://dx.doi.org/10.1007/s10555-008-9167-2
   PubMed Web of Science ®Google Scholar
• Zimonjic DB, Popescu NC. Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review). Internat J Oncol 2012; 41:393-406; PMID:22580498; http://dx.doi.org/10.3892/ijo.2012.1474
   PubMed Web of Science ®Google Scholar
• Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, Budhu A, Zhao X, Andersen JB, Ye QH, Jia HL, et al. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 2012; 56:1792-803; PMID:22707408; http://dx.doi.org/10.1002/hep.25890
   PubMed Web of Science ®Google Scholar
• Akhoondi S, Sun D, von der Lehr N, Apostolidou S, Klotz K, Maljukova A, Cepeda D, Fiegl H, Dafou D, Marth C, et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 2007; 67:9006-12; PMID:17909001; http://dx.doi.org/10.1158/0008-5472.CAN-07-1320
   PubMed Web of Science ®Google Scholar
• Yang H, Lu X, Liu Z, Chen L, Xu Y, Wang Y, Wie G, Chen Y. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells. Oncotarget 2015; 6:6310-25; PMID:25749036; http://dx.doi.org/10.18632/oncotarget.3355
   PubMed Web of Science ®Google Scholar
• Park MC, Kang T, Jin D, Han JM, Kim SB, Park YJ, Cho K, Park YW, Guo M, He W, et al. Secreted human glycyl-tRNA synthetase implicated in defense against ERK-activated tumorigenesis. Proc Natl Acad Sci USA 2012; 109:E640-7; PMID:22345558; http://dx.doi.org/10.1073/pnas.1200194109
   PubMedGoogle Scholar
• Paul R, Ewing CM, Robinson JC, Marshall FF, Johnson KR, Wheelock MJ, Isaacs WB. Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma. Cancer Res 1997; 57:2741-8; PMID:9205085
   PubMed Web of Science ®Google Scholar
• Sancisi V, Gandolfi G, Ragazzi M, Nicoli D, Tamagnini I, Piana S, Ciarrocchi A. Cadherin 6 is a new RUNX2 target in TGF-β signalling pathway. PloS One 2013; 8:e75489; PMID:24069422; http://dx.doi.org/10.1371/journal.pone.0075489
   PubMedGoogle Scholar
• Goeppert B, Schmezer P, Dutruel C, Oakes C, Renner M, Breinig M, Warth A, Vogel MN, Mittelbronn M, Mehrabi A, et al. Downregulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms. Hepatology 2010; 52:2023-33; PMID:20979053; http://dx.doi.org/10.1002/hep.23939
   PubMed Web of Science ®Google Scholar
• Collaboration OR. The ORFeome Collaboration: a genome-scale human ORF-clone resource. Nat Methods 2016; 13:191-2; PMID:26914201; http://dx.doi.org/10.1038/nmeth.3776
   PubMed Web of Science ®Google Scholar
• Yang X, Boehm JS, Yang X, Salehi-Ashtiani K, Hao T, Shen Y, Lubonja R, Thomas, SR, Alkan O, Bhimdi T, et al. A public genome-scale lentiviral expression library of human ORFs. Nat Methods 2011; 8:659-61; PMID:21706014; http://dx.doi.org/10.1038/nmeth.1638
   PubMed Web of Science ®Google Scholar
• Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L, Haeussler M, et al. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res 2014; 42:D764-70; PMID:24270787; http://dx.doi.org/10.1093/nar/gkt1168
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi.org/10.1006/meth.2001.1262
   PubMed Web of Science ®Google Scholar
• Cho S, Jang I, Jun Y, Yoon S, Ko M, Kwon Y, Choi I, Chang H, Ryu D, Lee B, et al. MiRGator v3.0: a microRNA portal for deep sequencing, expression profiling and mRNA targeting. Nucleic Acids Res 2013; 41:D252-7; PMID:23193297; http://dx.doi.org/10.1093/nar/gks1168
   PubMed Web of Science ®Google Scholar
• Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, Mesirov JP. Integrative genomics viewer. Nat Biotechnol 2011; 29:24-6; PMID:21221095; http://dx.doi.org/10.1038/nbt.1754
   PubMed Web of Science ®Google Scholar